Edgewise Therapeutics Grants Stock Options and Restricted Stock Units to Two New Employees

By Public Technologies
  • Edgewise Therapeutics granted inducement equity awards to two new non-executive employees on October 30, 2026, under its 2024 Inducement Equity Incentive Plan.
  • Awards included stock options to purchase 17,250 common shares and restricted stock units covering 8,626 common shares.
  • Options vest 25% on each employee's first employment anniversary, followed by monthly vesting of 1/48th of the shares.
  • Restricted stock units vest 25% on each of the first four grant-date anniversaries; all vesting requires continued service.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Edgewise Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA86277) on November 02, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk